Jocelyne Jacquemier

Jocelyne Jacquemier

UNVERIFIED PROFILE

Are you Jocelyne Jacquemier?   Register this Author

Register author
Jocelyne Jacquemier

Jocelyne Jacquemier

Publications by authors named "Jocelyne Jacquemier"

Are you Jocelyne Jacquemier?   Register this Author

93Publications

2105Reads

23Profile Views

Cytokeratin 7 as a predictive factor for response to concommitant radiochemotherapy for locally advanced cervical cancer: a preliminary study.

Anticancer Res 2014 Jan;34(1):177-81

Service de Chirurgie Oncologique, Institut Paoli Calmettes, 232, bd Sainte Marguerite, 13009 Marseille, France.

View Article

Download full-text PDF

Source
January 2014

ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program.

Cancer Res 2013 Dec 18;73(24):7290-300. Epub 2013 Oct 18.

Authors' Affiliations: INSERM, U1068, CRCM, Molecular Oncology, Institut Paoli-Calmettes, Biopathology, Aix-Marseille Univ, UM 105, F-13284, Départements d'Oncologie Médicale, Chirugie oncologique, and Radiologie, Institut Paoli-Calmettes, Marseille; and Plateforme ARN interference PArI, CEA SACLAY, Gif-sur-Yvette, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-4704DOI Listing
December 2013

Peripheral blood NK cells from breast cancer patients are tumor-induced composite subsets.

J Immunol 2013 Mar 28;190(5):2424-36. Epub 2013 Jan 28.

Centre de Recherche en Cancérologie de Marseille, INSERM Unité Mixte de Recherche 1068, 13009 Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1200140DOI Listing
March 2013

Breast metastasis of a squamous cell carcinoma of the uterine cervix mimicking inflammatory breast cancer.

Case Rep Oncol 2012 May 29;5(2):464-70. Epub 2012 Aug 29.

Department of Medical Oncology, Marseille, Hôpitaux de Mayotte, Mamoudzou, Saint-Denis, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000342255DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457040PMC
May 2012

Gene expression profiling and its utility in prediction of local relapse after breast-conserving therapy in early breast cancer.

Cancer Genomics Proteomics 2011 Jul-Aug;8(4):199-209

Department of Molecular Oncology, Marseille Cancer Research Center, Paoli Calmettes Institute, UMR891 Inserm, Marseille, France.

View Article

Download full-text PDF

Source
http://cgp.iiarjournals.org/content/8/4/199.full.pdf
Web Search
December 2011

Peritumoural vascular invasion: a major determinant of triple-negative breast cancer outcome.

Eur J Cancer 2011 Jul 8;47(10):1537-45. Epub 2011 Mar 8.

Molecular Oncology Department, Centre de Recherche en Cancérologie de Marseille, UMR891 Inserm, Institut Paoli-Calmettes, Marseille, France.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S095980491100085
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2011.02.002DOI Listing
July 2011

Kinome expression profiling and prognosis of basal breast cancers.

Mol Cancer 2011 Jul 21;10:86. Epub 2011 Jul 21.

Department of Molecular Oncology, Centre de Recherche en Cancérologie de Marseille, UMR891 Inserm, Institut Paoli-Calmettes, 27 bd Leï Roure, 13009 Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-4598-10-86DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156788PMC
July 2011

A gene expression signature identifies two prognostic subgroups of basal breast cancer.

Breast Cancer Res Treat 2011 Apr 21;126(2):407-20. Epub 2010 May 21.

Département d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille, UMR891 Inserm, Institut Paoli-Calmettes, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-0897-9DOI Listing
April 2011

Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors.

Anticancer Res 2011 Mar;31(3):1079-86

Oncologie Médicale, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, INSERM U891, 232, boulevard Sainte Marguerite, 13009 Marseille, France.

View Article

Download full-text PDF

Source
March 2011

Sonographic appearance of a metastasis to the breast from a cerebellar medulloblastoma.

J Clin Ultrasound 2010 Jul;38(6):335-7

Department of Radiology, Institut Paoli-Calmettes, 232 Bvd Sainte Margueritte, 13009 Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcu.20698DOI Listing
July 2010

Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer.

Breast Cancer Res 2009 30;11(2):R23. Epub 2009 Apr 30.

Département d'Oncologie Moléculaire Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, UMR891 Inserm, IFR137, 232 Bd sainte Marguerite Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr2249DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688952PMC
August 2009

CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.

Breast Cancer Res 2009 5;11(1):R1. Epub 2009 Jan 5.

Institut Paoli-Calmettes, Centre de Ressources Biologiques en Oncologie, Centre de Thérapie Cellulaire et Génique, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr2215DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687703PMC
June 2009

[Diagnostic pitfalls in mammary pathology. Case 5. Secretory carcinoma].

Ann Pathol 2009 Jun 21;29(3):211-5. Epub 2009 Jun 21.

Institut Paoli-Calmettes, 232, boulevard Sainte-Marguerite, BP 156, 13273 Marseille cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2009.02.010DOI Listing
June 2009

How different are luminal A and basal breast cancers?

Int J Cancer 2009 Mar;124(6):1338-48

Département d'Oncologie Moléculaire, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, UMR891 Inserm, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.24055DOI Listing
March 2009

Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis.

Cancer Res 2008 Feb;68(3):767-76

UMR599 Inserm, Institut Paoli-Calmettes, Laboratoire d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-5516DOI Listing
February 2008

Integrated profiling of basal and luminal breast cancers.

Cancer Res 2007 Dec;67(24):11565-75

Marseille Cancer Research Center, Department of Molecular Oncology, Institut Paoli-Calmettes and UMR599 Institut National de la Santé et de la Recherche Médicale, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-2536DOI Listing
December 2007

Moesin expression is a marker of basal breast carcinomas.

Int J Cancer 2007 Oct;121(8):1779-85

Laboratory of Molecular Oncology, Marseille Cancer Research Institute, UMR599 Inserm/Institut Paoli-Calmettes, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.22923DOI Listing
October 2007

[Towards an integrated cellular and molecular: definition of breast cancers].

Med Sci (Paris) 2007 Jun-Jul;23(6-7):626-32

UMR 599 Inserm, Institut Paoli-Calmettes, Laboratoire d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille et Université de la Méditerranée, 27, boulevard Leï Roure, 13009 Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/20072367626DOI Listing
September 2007

Inflammatory breast cancers in Tunisia and France show similar immunophenotypes.

Breast 2007 Aug 13;16(4):352-8. Epub 2007 Mar 13.

Institut de Cancérologie de Marseille, Département d'Oncologie Moléculaire, Institut Paoli-Calmettes et UMR599 Inserm, IFR137 Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2007.01.002DOI Listing
August 2007

Value of the sentinel lymph node procedure in patients with large size breast cancer.

Ann Surg Oncol 2007 Feb 12;14(2):621-6. Epub 2006 Nov 12.

Department of Surgery, Institut Paoli-Calmettes, 232 Bd Sainte Marguerite, Marseilles, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-006-9232-4DOI Listing
February 2007

[Impact on the quality of pathology reports in the R2c cancer network: analysis of 4521 pathology reports of primary breast tumors].

Bull Cancer 2006 Oct;93(10):1033-8

Département d'information médicale et biostatistique, Institut Paoli-Calmettes, 232, boulevard Sainte-Marguerite, 13273 Marseille Cedex 09.

View Article

Download full-text PDF

Source
October 2006

Prognosis and gene expression profiling of 20q13-amplified breast cancers.

Clin Cancer Res 2006 Aug;12(15):4533-44

Laboratoire d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille, UMR599 Inserm, Marseilles, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-2339DOI Listing
August 2006

Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer.

Gynecol Oncol 2006 Jul 10;102(1):74-9. Epub 2006 Jan 10.

Department of Surgery, Institut Paoli-Calmettes, 232 Bd Sainte Marguerite, 13009 Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2005.11.037DOI Listing
July 2006

Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers.

Cancer Res 2006 May;66(9):4636-44

Institut de Cancérologie de Marseille, Département d'Oncologie Moléculaire, Institut Paoli-Calmettes et Unité Mixte de Recherche 599 Institut National de la Santé et de la Recherche Médicale, Marseilles, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-0031DOI Listing
May 2006

How to best classify breast cancer: conventional and novel classifications (review).

Int J Oncol 2005 Nov;27(5):1307-13

Marseille Cancer Institute, Laboratory of Molecular Oncology, UMR599 Inserm, Marseille, France.

View Article

Download full-text PDF

Source
November 2005

ETV6 gene rearrangements in invasive breast carcinoma.

Genes Chromosomes Cancer 2005 Sep;44(1):103-8

Marseille Cancer Institute, Laboratory of Molecular Oncology, Institut Paoli-Calmettes and UMR599 Inserm, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20200DOI Listing
September 2005

Junctional recruitment of mammalian Scribble relies on E-cadherin engagement.

Oncogene 2005 Jun;24(27):4330-9

Marseille Cancer Institute, Molecular Pharmacology, UMR 599 Inserm-Institut Paoli-Calmettes, 27 boulevard Leï Roure 13009 Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1208632DOI Listing
June 2005

Gene expression profiling identifies molecular subtypes of inflammatory breast cancer.

Cancer Res 2005 Mar;65(6):2170-8

Institut de Cancérologie de Marseille, Laboratoire d'Oncologie Moléculaire, Institut Paoli-Calmettes and UMR599 Institut National de la Santé et de la Recherche Médicale, IFR137, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-4115DOI Listing
March 2005

Protein expression profiling identifies subclasses of breast cancer and predicts prognosis.

Cancer Res 2005 Feb;65(3):767-79

Institut de Cancérologie de Marseille, Département d'Oncologie Moléculaire, Institut Paoli-Calmettes and UMR599 INSERM, 27 Boulevard Leï Roure, Marseille, France.

View Article

Download full-text PDF

Source
February 2005

[What is new about sentinel lymph node biopsy in breast cancer?].

Bull Cancer 2004 Dec;91 Suppl 4:S216-20

Département de chirurgie, Institut Paoli-Calmettes, 232 bd Sainte-Marguerite, 13006 Marseille cedex 9.

View Article

Download full-text PDF

Source
December 2004

[Sentinel lymph node negative breast cancer larger than 30 mm: is axillary lymph node dissection constantly necessary?].

Bull Cancer 2004 Dec;91 Suppl 4:S221-5

Départements de chirurgie, Institut Paoli-Calmettes, 232 bd Sainte-Marguerite, 13006 Marseille Cedex 9.

View Article

Download full-text PDF

Source
December 2004

Basal and luminal breast cancers: basic or luminous? (review).

Int J Oncol 2004 Aug;25(2):249-58

Laboratoire d'Oncologie Moléculaire, Institut Paoli-Calmettes and UMR599 Inserm, 13009 Marseille, France.

View Article

Download full-text PDF

Source
August 2004

Identification and validation of an ERBB2 gene expression signature in breast cancers.

Oncogene 2004 Apr;23(14):2564-75

Département d'Oncologie Moléculaire, Institut Paoli-Calmettes and UMR119 Inserm, IFR57, and Faculté de Médecine, Université de la Méditerranée, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1207361DOI Listing
April 2004

[Small but high throughput: how "tissue-microarrays" became a favorite tool for pathologists and scientists].

Ann Pathol 2003 Dec;23(6):623-32

Département d'Oncologie Moléculaire, Institut Paoli-Calmettes, 232 Bd de Sainte Marguerite, 13273 Marseille Cedex 9, France.

View Article

Download full-text PDF

Source
December 2003

TACC1-chTOG-Aurora A protein complex in breast cancer.

Oncogene 2003 Nov;22(50):8102-16

Department of Molecular Oncology, U119 Inserm, Institut Paoli-Calmettes, IFR57, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1206972DOI Listing
November 2003

A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene.

Genes Chromosomes Cancer 2003 Aug;37(4):333-45

Département d'Oncologie Moléculaire, Laboratoires de Cytogénétique Moléculaire et de Pathologie Moléculaire, U119 Institut National de la Santé et de la Recherche Médicale (INSERM) and Institut Paoli-Calmettes (IPC), Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.10218DOI Listing
August 2003

Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?

J Nucl Med 2003 Aug;44(8):1232-7

Department of Nuclear Medicine, Institut Paoli-Calmettes, Regional Cancer Center, Université de la Méditerranée, 232 Boulevard Sainte Marguerite, 13273 Marseille Cedex 9, France.

View Article

Download full-text PDF

Source
August 2003

[Risk of stage underestimation of breast cancer by sentinel lymph node biopsy method].

Bull Cancer 2003 May;90(5):467-73

Institut Paoli-Calmettes, 232, boulevard de Sainte-Marguerite, 13273 Marseille Cedex 9.

View Article

Download full-text PDF

Source
May 2003

[Tissue microarrays a powerful tool in transfer and quality control in oncology].

Bull Cancer 2003 Jan;90(1):31-8

Département d'oncologie moléculaire, Institut Paoli-Calmettes, 232, bd de Sainte-Marguerite, 13273 Marseille Cedex 9.

View Article

Download full-text PDF

Source
January 2003

Prognosis of breast cancer and gene expression profiling using DNA arrays.

Ann N Y Acad Sci 2002 Dec;975:217-31

Département d'Oncologie Moléculaire, TAGC, Institut Paoli-Calmettes (IPC), IFR57, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1749-6632.2002.tb05954.xDOI Listing
December 2002

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

J Clin Oncol 2002 May;20(9):2310-8

Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research and the Royal Marsden Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2002.09.023DOI Listing
May 2002